Completed NA INTERVENTIONAL 1-arm NCT02084797

V2 Receptor Effects on Fluid Regulation and Performance

Revisiting the Human Sweat Gland - Does Arginine Vasopressin Modulate Sweat Sodium Concentration Via the V2 Receptor?

Sponsor: Georgetown University

Conditions Electrolyte Imbalance Hypernatremia Hyponatremia

Interventions V2R (Vasopressin 2 receptor)

Updated 8 times since 2017 Last updated: Apr 6, 2016 Started: Jun 30, 2011 Primary completion: Oct 31, 2011 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Electrolyte Imbalance and Hypernatremia, this trial is completed. The trial is conducted by Georgetown University and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Georgetown University
Oakland University

Data source: Oakland University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States